Trial intelligence / Profile preview

PTH(1-84) versus alendronate for back pain in postmenopausal women with osteoporosis-related vertebral fractures

2006-006064-32Phase 4Completed

Sponsor
Nycomed
Start
Dec 2007
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in postmenopausal osteoporosis comparing Preotact arm with Alendronate arm (2 arms). Primary endpoint: Change in back pain intensity. Started Dec 2007; status: completed.

02

Drugs

parathyroid hormone 1-84alendronate
03

Conditions

postmenopausal osteoporosis

Beyond the preview

Go deeper on 2006-006064-32.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-006064-32.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call